NervGen Pharma Corp. (TSXV:NGEN)

NervGen Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.27	11.66	22.45	16.93	5.6
Cash & Short-Term Investments	17.27	11.66	22.45	16.93	5.6
Cash Growth	48.10%	-48.07%	32.62%	202.38%	36.34%
Accounts Receivable	0.1	-	-	-	-
Other Receivables	0.42	0.25	0.03	0.06	0.06
Receivables	0.51	0.25	0.03	0.06	0.06
Prepaid Expenses	0.18	0.11	0.08	0.07	0.05
Other Current Assets	1.05	0.5	0.59	0.36	0.49
Total Current Assets	19.01	12.52	23.15	17.42	6.2
Property, Plant & Equipment	-	0.2	0.3	0	0
Other Intangible Assets	0.46	0.52	0.43	0.47	0.47
Long-Term Accounts Receivable	0.01	-	-	-	-
Total Assets	19.49	13.24	23.88	17.9	6.68
Accounts Payable	-	3.32	2	0.35	0.17
Accrued Expenses	4.94	-	1.4	0.73	0.58
Current Portion of Leases	0.1	0.09	0.09	-	-
Other Current Liabilities	11.86	11.73	6.73	-	-
Total Current Liabilities	16.9	15.14	10.22	1.08	0.76
Long-Term Leases	0.01	0.11	0.2	-	-
Total Liabilities	16.91	15.25	10.41	1.08	0.76
Common Stock	81.1	58.93	57.41	42.4	22.95
Retained Earnings	-102.16	-78.15	-55.77	-35.05	-22.32
Comprehensive Income & Other	23.64	17.21	11.82	9.46	5.3
Shareholders' Equity	2.58	-2.01	13.46	16.82	5.92
Total Liabilities & Equity	19.49	13.24	23.88	17.9	6.68
Total Debt	0.11	0.2	0.28	-	-
Net Cash (Debt)	17.16	11.46	22.17	16.93	5.6
Net Cash Growth	49.72%	-48.29%	30.95%	202.38%	36.34%
Net Cash Per Share	0.25	0.19	0.42	0.43	0.17
Filing Date Shares Outstanding	70.99	69.93	59.13	46.23	35.86
Total Common Shares Outstanding	70.33	59.61	58.78	46.19	35.17
Working Capital	2.11	-2.62	12.93	16.34	5.45
Book Value Per Share	0.04	-0.03	0.23	0.36	0.17
Tangible Book Value	2.11	-2.53	13.03	16.35	5.45
Tangible Book Value Per Share	0.03	-0.04	0.22	0.35	0.15

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.